[{"Assets_0_Q3_USD":"1218500000.0","CIK":"899923","CommonStockSharesConverted_0_Q3_shares":"69900000.0","CommonStockSharesOutstanding_0_Q3_shares":"69900000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.16","EarningsPerShareBasic_3_Q3_USD":"1.8","EarningsPerShareDiluted_1_Q3_USD":"0.16","EarningsPerShareDiluted_3_Q3_USD":"1.74","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","MinorityInterest_0_Q3_USD":"100000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"68000000.0","NetIncomeLoss_1_Q3_USD":"11400000.0","NetIncomeLoss_3_Q3_USD":"124600000.0","OfficialName":"Myriad Genetics Inc. Common Stock","ProfitLoss_1_Q3_USD":"11300000.0","ProfitLoss_3_Q3_USD":"124400000.0","RevenuesConverted_1_Q3_USD":"193500000.0","RevenuesConverted_3_Q3_USD":"577700000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":"948400000.0","StockholdersEquity_0_Q3_USD":"948300000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"72400000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"71700000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"69800000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"69200000.0","filed":"20180509","footnote":null,"form":"10-Q","fp":"Q3","fy":"2018.0","name":"MYRIAD GENETICS INC","period":"20180331","qtrs":"0","uom":"USD"}]